NOVAVAX, INC.
502086-9508ActiveDeveloping innovative protein-based vaccines using proprietary adjuvant technology.
Biotechnology/Pharmaceutical Companynovavax.com
Yleiskatsaus
- 0
- Työntekijät
- 1–2.5milj SEK
- Liikevaihto
- 2021
- Perustettu
Avainpäättäjät
Rick Crowley
Executive Vice President, Chief Operations Officer
Jane Shershenovich
Vice President, Chief Intellectual Property Counsel, Legal
Jim Kelly
Executive Vice President, Chief Financial Officer and Treasurer
Elaine O’Hara
Executive Vice President, Chief Strategy Officer
+17 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Novavax is a biotechnology company dedicated to developing life-saving vaccines to prevent serious illnesses globally. Its core strength lies in a proprietary technology platform combining recombinant protein-based nanoparticles with their specialized Matrix-M adjuvant. This platform is designed to...
VALNEVA SWEDEN AB